The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma - Wikidata - awgldk - TriplyDB

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

http://www.wikidata.org/entity/Q34170367

about

Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells Targeting Selectins and Their Ligands in Cancer Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma.Multiple myeloma in the marrow: pathogenesis and treatments.Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy Induction of Siglec-1 by Endotoxin Tolerance Suppresses the Innate Immune Response by Promoting TGF-β1 Production.Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.Sialic acids: biomarkers in endocrinal cancers.New therapeutic targets for cancer bone metastasis Sialic acids in cancer biology and immunity.MiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5.Sialyltransferase ST3GAL6 mediates the effect of microRNA-26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathway Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271.Update on elotuzumab, a novel anti-SLAMF7 monoclonal antibody for the treatment of multiple myeloma.Targeting the Bone Marrow Microenvironment.A perspective on malignancy in the marrow.Galectin-8 enhances adhesion of multiple myeloma cells to vascular endothelium and is an adverse prognostic factor.Low intensity vibration mitigates tumor progression and protects bone quantity and quality in a murine model of myeloma.DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.GFAPδ/GFAPα ratio directs astrocytoma gene expression towards a more malignant profile.N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma.Combination therapy with the type II anti-CD20 antibody obinutuzumab.Reflections on Cancer in the Bone Marrow: Adverse Roles of Adipocytes.Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt/mTOR-mediated pathway in pancreatic cancer cells.Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.Capillary electrophoresis analysis of N-glycosylation changes of serum paraproteins in multiple myeloma.Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.3d Tissue Engineered In Vitro Models Of Cancer In Bone Multiple Roles of Glycans in Hematological Malignancies

P2860

Q26744596-C65AD11E-AEE8-45B7-B44B-130977FDDA0C Q26752384-3E6FC50C-3D56-4C19-A85A-87F9CE9531D8 Q26778227-C7BA9D87-167C-4519-810D-1F224B2D707B Q30039640-542AA769-899E-4A75-9CDD-313BFEB66584 Q35663623-393F5DE7-58B9-4092-AACC-E7705B821C21 Q36725401-800206E3-4C22-4FF5-A480-0F55AE75AA0F Q36737884-9868A1F6-189A-4D1B-A7D9-66F3A02364B1 Q37066067-F2EF03CE-3339-49AF-938E-59A8BEAE7DF6 Q37101382-25363492-AAAD-48DF-953B-249F9D90AD1D Q37746021-A71E33D9-6317-47EB-8162-3431399446B8 Q38380548-EE5FCB66-620E-46F7-B8D5-297E210BEE6D Q38473066-5291E55A-4E3A-4DEC-BECF-6AC489D60D54 Q38620799-CD1F6E33-C431-467E-9DF7-FC574DD3C695 Q38715650-D212C093-F7C3-42F9-AF4D-98B45D764720 Q38728098-4DEF8606-CB00-467C-B6A2-5D3A250395CE Q38759700-47E57213-3B97-45CC-98A3-BA0A6346D2FA Q38821948-6D4310C1-8A7B-4496-B7FF-D855E9CCA967 Q38929980-E0012510-08BE-48BB-A816-43369E28A265 Q38970585-E0787878-BC75-44FD-9E7A-487FCC078E49 Q39138403-5EFF9076-807F-403E-8CAA-B44AF0877E56 Q39692497-F544CCEB-51D5-4CE7-8C77-5D33F4841C37 Q42221103-3E5F4801-EA23-411A-A3CA-CF59E63F80B9 Q44157344-C5EBBBFD-DB49-44BB-B3BA-6F05E843DC78 Q46442341-91480F7A-B9CB-4DB9-B7E9-087B008E7C73 Q47103846-D0558B5A-224A-4F32-B88C-0A76DA77D328 Q47138416-C0E7E563-3B52-40F8-A95C-2025EA63F2EB Q47898168-28404A40-12A4-4A8F-8513-286D8D20002A Q49333283-198F8ACB-D17A-4C3B-9E1C-AAF254BC5C05 Q50055562-B0FF34DB-252B-4645-B02A-780295C61A1C Q50182712-7B81A939-57D5-4975-8279-E6382D1D4C16 Q51172126-B119E600-712A-414B-861C-ABA6F4CB3B73 Q55515607-5925E2C0-E5C1-41E5-ACDE-8334FA5F10C2 Q57215522-DCDAE4EA-0D71-4171-8317-D43A6FD277DD Q58761454-9913B70B-EEB3-4966-89C2-587443DA2021

P2860

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

http://www.wikidata.org/entity/Q34170367

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@ast

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@en

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@nl

type

label

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@ast

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@en

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@nl

prefLabel

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@ast

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@en

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@nl

P1433

Q34170367-36A44DF6-F43A-408C-8D06-ADF432466A60

P1476

Q34170367-AE67AA89-2278-4535-8DCE-0D827C4E1C21

P2093

Q34170367-210D4E27-EF7D-4A50-BB89-A775F94D6779

Q34170367-37B3C54F-67B0-4E53-BB82-FA91DE25180A

Q34170367-4E4B1F6D-BFA7-4CC7-B893-D14DAEA13A06

Q34170367-50AE9F7F-B9C3-4B8E-8923-6C0F91C4BC4B

Q34170367-52D902E0-7B45-42A2-BE75-3D0CB2F94EDD

Q34170367-7C8EE94D-D5D4-4B24-80CA-BD8BB94A9F2F

Q34170367-7E828363-9AC3-4DBC-84F7-EC8A4D75FFA0

Q34170367-9370EA3B-7E2C-44EB-8E02-74CA4025B7E3

Q34170367-9CFCD5E4-61B5-49C3-BBDD-38427CCB7FC7

Q34170367-B9FDB200-1AB7-41DA-B5EE-148240D6C01D

P2860

Q34170367-04ACEB29-4C7E-49E7-960F-C0B0F9DEB1FF

Q34170367-0AB2CEFA-92D3-42EE-AEC1-06155EC05AF0

Q34170367-1082CCEA-7372-4493-9378-DB555D29C75E

Q34170367-12EA343F-D1DE-41FF-84D3-B8A35562EF3C

Q34170367-224A69C7-E3D0-4D70-872E-094A3B937A51

Q34170367-23BDCCEF-68CD-46BB-8274-A2B3C83EAA58

Q34170367-2AFBC962-ABBC-499D-BA8C-CD5407CE3895

Q34170367-2EE38466-274D-4992-AB75-259942E31CD3

Q34170367-37069817-706A-4C56-81EE-95CD5FEB5C53

Q34170367-459C4084-FBB7-4715-A4A9-2264A88CFD95

P304

Q34170367-686B68A4-C350-452F-93F1-377B293665ED

P31

Q34170367-A93F6C33-57F6-48F0-9F49-31BD133F3B3D

P356

Q34170367-14032DE0-6594-48D5-9CD9-F597F376E3EC

P407

Q34170367-BDBBC7AD-E121-4097-90E5-5EBFB8EC1FE1

P433

Q34170367-CCA286B0-0E11-43F2-8C61-F4308FD119D9

P478

Q34170367-F2A0BFB5-5D19-4F87-934F-09BAF6C5B09F

P50

Q34170367-08E51424-D43C-4E21-877E-B98F5B7F2D8B

Q34170367-48297D1E-8E85-42C7-8321-C7DE830F0187

Q34170367-72F288F3-CBE4-49B4-83D9-3DE80D4D59D5

Q34170367-7CCA3852-D1F7-4B60-9D89-76943BD37B02

Q34170367-81E03151-E1C1-4A5C-9A70-E9C7B6A7F9B1

Q34170367-C932F74D-FD46-4228-9FE3-1525FDA3DB9B

Q34170367-CEBC9341-0181-456C-A8A0-9F390C3B023D

P577

Q34170367-68DC1D4B-6596-4136-904E-A48E0FFD043D

P5875

Q34170367-856B1E4A-08DF-492C-997C-B150D47AC8DE

P698

Q34170367-F0D854F5-EC18-42B4-BA08-28BE662B20F5

P932

Q34170367-B27DAEFA-8880-4077-9716-10706CABBDDC

P356

BLOOD-2014-03-560862

P1433

P1476

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

@en

P2093

Ilyas Sahin

http://www.w3.org/2001/XMLSchema#string

Irene M Ghobrial

http://www.w3.org/2001/XMLSchema#string

Laura S Murillo

http://www.w3.org/2001/XMLSchema#string

Michele Moschetta

http://www.w3.org/2001/XMLSchema#string

Ping Wu

http://www.w3.org/2001/XMLSchema#string

Salomon Manier

http://www.w3.org/2001/XMLSchema#string

Siobhan V Glavey

http://www.w3.org/2001/XMLSchema#string

Wenjing Zhang

http://www.w3.org/2001/XMLSchema#string

Yong Zhang

http://www.w3.org/2001/XMLSchema#string

Yu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration

P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow.

In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin.

Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates.

The glycome of normal and malignant plasma cells

P304

1765-1776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-03-560862

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Michaela R. Reagan

Michael O'Dwyer

Alessandro Natoni

Gareth J Morgan

P577

2014-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264246028

http://www.w3.org/2001/XMLSchema#string

P698

25061176

http://www.w3.org/2001/XMLSchema#string

P932

4162107

http://www.w3.org/2001/XMLSchema#string